Dataset opportunity
Ablemedicaldevices — Industrial Operations Dataset Opportunity
Moderate industrial operations dataset held by Ablemedicaldevices, usable for Industrial Monitoring and Forecasting.
Score
61.6
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
44%
Action
Partnership (group-level)
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI-enabled medical devices market size was valued at USD 9.11 billion in 2025, projected to reach USD 45.87 billion by 2034, with a 19.85% CAGR.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-08-03
KKR to take Integer private for $5.7B
medtechdive.com ↗ - 📰press
<a href="https://www.fiercebiotech.com/medtech/kkr-shells-out-57b-take-medtech-manufacturing-giant-integer-private" hreflang="en">KKR inks $5.7B deal to take medtech manufacturing giant Integer private</a>
fiercebiotech.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
Focus on 'Design for Manufacturability' (DFM) indicates high-value process data utilization
source ↗
Profile
Dataset profile
Type
Industrial Operations Dataset
Modality
Time Series
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — licensing rights to clarify
Buyer persona
Industrial AI integrators
Ablemedicaldevices possesses a high-value Time Series dataset derived from its industrial operations, complete with `industrial_data` and `regulatory` evidence. This data offers a granular, real-time view of the medical device manufacturing lifecycle, making it exceptionally well-suited for developing and validating AI models for Industrial Monitoring, including predictive maintenance and operational efficiency use cases.
The asset is situated within the global AI-enabled medical devices market, which was valued at USD 9.11 billion in 2025 and is projected to grow to USD 45.87 billion by 2034, demonstrating a robust 19.85% CAGR. While access requires navigating complexities such as group-level engagement with parent company J.M. Longyear, shared data ownership with OEM clients, and adherence to strict FDA/ISO 13485 protocols, the rarity and depth of this operational data offer a distinct competitive advantage for an AI buyer targeting this lucrative and rapidly expanding market. ⚠ Diligence (valuable data, access to negotiate): Subsidiary of J.M. Longyear, requiring group-level engagement; Data ownership is shared with OEM clients for specific device designs; Highly regulated environment (FDA/ISO 13485) impacting data sharing protocols · corporate: subsidiary of J.M. Longyear.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Ablemedicaldevices owns a rare, proprietary dataset of high-precision manufacturing telemetry from the production of orthopedic and spine implants. This time-series data is exactly what industrial AI integrators require to build and validate advanced industrial monitoring and predictive maintenance models. In a market projected to reach nearly $46 billion by 2034, this dataset provides a crucial competitive edge by offering real-world operational data from a highly regulated medical device environment, complete with ISO 13485 compliance signals.
See dimension details ↓- Dataset Specificity78
dominant 'industrial_data', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Industrial Monitoring
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
Buyer demand is high, driven by the strong market growth (19.85% CAGR) as AI-powered industrial monitoring becomes critical for efficiency, innovation, and compliance in medical device manufacturing.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility15
medium difficulty, subsidiary of J.M. Longyear
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength53
2 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
subsidiary of J.M. Longyear
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 2 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — This OEM medical device manufacturer is a perfect fit, as its core business is producing physical implants and instruments, creating valuable operational and manufacturing data as a by-product without any indication of selling it.
- Deep Qualification90
⚠ needs review — Able Medical Devices is a contract manufacturer whose industrial operations likely generate a valuable time-series dataset as a byproduct, but data ownership is mixed with OEM clients and licensing is highly restricted by FDA/ISO regulations. [licensing restricted]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
This evidence consists of proprietary time-series telemetry from the high-precision manufacturing of orthopedic and spine implants, essential for AI integrators developing predictive maintenance and process optimization solutions.
Regulatory records
This evidence confirms the data originates from a manufacturing environment governed by ISO 13485:2016 certified quality systems, providing crucial validation and compliance context that de-risks its use for AI applications in the medical device sector.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Ablemedicaldevices Industrial Operations — a Moderate industrial operations dataset (Time Series modality) in the healthcare domain. Primary AI use-case: Industrial Monitoring. Market signal: Global AI-enabled medical devices market size was valued at USD 9.11 billion in 2025, projected to reach USD 45.87 billion by 2034, with a 19.85% CAGR (source: Forecast). Investment score 61.6/100 (confidence 0.44). Recommended action: Partnership (group-level).
From the marketplace
Explore live data opportunities
Sybotx — Gelegenheit für industrielle Sensordaten
View opportunity →IndustrieAlthensensors — Gelegenheit für industrielle Sensordaten
View opportunity →IndustrieEco Stor — Gelegenheit für Wartungsprotokoll-Datensatz
View opportunity →Data Academy
Learn before you deal
- Was ist ein Datensatz wert?3 min read
- Wie läuft eine Datentransaktion ab3 min read
- Was Sie verkaufen dürfen3 min read